Additionally, increased miR-155 levels in various immune cell populations, including CD4+ and CD8+ T cell, M1 tumor-associated macrophages (TAMs), dendritic cells (DCs), and natural killer cells, can enhance their anti-tumor activity. The gene discussed is CD8A; the disease is neoplasm.